Plunkett Research Online: Vital Therapies Inc

VITAL THERAPIES INC (VTL:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Vital Therapies Inc is a biotherapeutic company. It is involved in the business of developing liver treatment to improve survival in patients with Liver failure by providing hepatic support continuously for up to five days. The firm's main product candidate is ELAD system. It also owns VTL C3A cell .....



Vital Therapies Inc
Ticker: VTL
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 858 673-6840
Fax: 858 673-6843
Address: 15010 Avenue of Science
Suite 200
San Diego, CA 92128 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Scientific Research and Development (R&D) in Life Sciences, Medical Devices, Biotechnology and Pharmaceuticals (Drugs)
ContactsDescription
Terence WintersCEO/Co-Chairman/Director
Michael SwansonCFO/Chief Accounting Officer/Executive VP
See More
Vital Therapies Inc is a biotherapeutic company. It is involved in the business of developing liver treatment to improve survival in patients with Liver failure by providing hepatic support continuously for up to five days. The firm's main product candidate is ELAD system. It also owns VTL C3A cell .....See More See More

Auditor: PricewaterhouseCoopers LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: